tiprankstipranks
Trending News
More News >
Stepan Company (SCL)
NYSE:SCL
Advertisement

Stepan Company (SCL) AI Stock Analysis

Compare
176 Followers

Top Page

SCL

Stepan Company

(NYSE:SCL)

Rating:65Neutral
Price Target:
$54.00
▲(10.93% Upside)
The overall stock score is primarily influenced by a stable financial performance and positive earnings call, despite technical indicators showing bearish trends. The valuation suggests moderate overvaluation but is balanced by a strong dividend yield. The company’s strategic growth initiatives in key segments offer a promising outlook, despite current challenges.

Stepan Company (SCL) vs. SPDR S&P 500 ETF (SPY)

Stepan Company Business Overview & Revenue Model

Company DescriptionStepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. It serves in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.
How the Company Makes MoneyStepan Company generates revenue primarily through the production and sale of specialty chemicals, which are utilized across various industries. The company has several key revenue streams, including surfactants for home and personal care products, agricultural products, and polyurethane systems. Additionally, Stepan benefits from strategic partnerships with leading companies in the consumer goods and agricultural sectors, which enhance its market reach and product offerings. Factors contributing to its earnings include a strong focus on research and development, a diversified product portfolio, and a commitment to sustainability, allowing Stepan to meet customer demands while maintaining competitive pricing.

Stepan Company Earnings Call Summary

Earnings Call Date:Jul 30, 2025
(Q2-2025)
|
% Change Since: -11.88%|
Next Earnings Date:Oct 15, 2025
Earnings Call Sentiment Neutral
The earnings call reflects a mixed performance with robust growth in adjusted net income and EBITDA, supported by strong results in the Polymers and Crop Productivity sectors. However, the company faced margin pressures due to raw material costs, negative free cash flow, and costs related to environmental and regulatory issues. Despite these challenges, there is optimism about future growth driven by production ramp-up at the new facility and strategic market expansions.
Q2-2025 Updates
Positive Updates
Adjusted EBITDA Growth
The company reported second quarter adjusted EBITDA of $51.4 million, up 8% versus the prior year. Polymers delivered double-digit adjusted EBITDA growth.
Net Income Increase
The company finished the second quarter of 2025 with $12 million of adjusted net income, up 27% versus the prior year, driven by earnings growth in polymers and crop productivity as well as a lower tax rate.
Production Expansion
Production at the new Pasadena, Texas site is ramping up and should provide incremental benefits in the second half of the year. Specialty alkoxylation volumes continue to grow strong double digits in the second quarter.
Dividend Payments
During the second quarter of 2025, the company paid $8.7 million in dividends to shareholders. The company has increased its dividend for 57 consecutive years.
Surfactant Selling Price Increase
Surfactant net sales were $411.5 million for the quarter, an 8% increase versus prior year. Selling prices were up 11%, primarily due to improved product and customer mix.
Negative Updates
Surfactant Margin Pressure
Significantly higher oleochemical raw material costs continue to impact Surfactant margins. Surfactant adjusted EBITDA decreased $0.5 million or 1% versus the prior year.
Negative Free Cash Flow
Free cash flow was negative at $14.4 million for the second quarter, down $14.2 million year-over-year, reflecting higher working capital requirements and increased purchases of raw materials.
Environmental and Regulatory Costs
Earnings growth was impacted by higher start-up expenses at the Pasadena, Texas facility, an environmental remediation reserve adjustment at the Millsdale site, and an EPA penalty.
Specialty Products EBITDA Decline
Specialty Products adjusted EBITDA decreased $2.1 million or 24%, primarily due to order timing fluctuations within the Pharmaceutical business.
China Polymers Volume Decline
China Polymers volume was down low double digits, reflecting challenging market conditions.
Company Guidance
During the Stepan Company's Second Quarter 2025 Earnings Conference Call, several key financial metrics and strategic updates were discussed. The company reported an adjusted EBITDA of $51.4 million, reflecting an 8% increase from the previous year, driven primarily by double-digit growth in the Polymers segment, although Surfactants experienced a slight decline due to high oleochemical raw material costs. Adjusted net income rose by 27% to $12 million, with improvements attributed to earnings growth in Polymers and Crop Productivity segments, alongside a lower effective tax rate of 19.2%, down from the usual 24-26%. Despite these gains, free cash flow was negative at $14.4 million due to inventory builds and start-up expenses at the new Pasadena facility. The company also announced a $0.385 per share quarterly dividend, marking the 57th consecutive year of dividend increases. Looking ahead, Stepan aims to recover Surfacent margins and anticipates additional benefits from the Pasadena site ramp-up and strategic asset optimizations, including the planned sale of their Philippines site by the fourth quarter of 2025.

Stepan Company Financial Statement Overview

Summary
The company shows stable revenue and operational efficiency with a solid balance sheet characterized by conservative leverage. Profitability margins suggest room for improvement, but strong cash flow performance indicates robust operational cash generation.
Income Statement
75
Positive
The company shows a stable revenue base with a slight TTM revenue increase of 1.9% compared to the previous annual period. Gross profit margin for TTM is 12.5%, reflecting consistent operational efficiency, though slightly lower than historical figures. Net profit margin for TTM is 2.53%, indicating room for improvement in profitability. EBIT and EBITDA margins at 3.54% and 8.62% respectively, suggest moderate operational efficiency typical for the industry.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial structure with a debt-to-equity ratio of 0.55, which is relatively conservative and indicative of manageable leverage. The equity ratio stands at 50.2%, showcasing a solid equity base. Return on equity for TTM is 4.68%, which, although positive, suggests potential for enhancing shareholder returns.
Cash Flow
68
Positive
The company's cash flow shows a favorable operating cash flow to net income ratio of 2.15 for TTM, highlighting strong cash generation relative to earnings. Free cash flow has improved significantly in the latest period, although historical volatility in free cash flow to net income ratio indicates potential cash flow management challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.22B2.18B2.33B2.77B2.35B1.87B
Gross Profit277.39M272.21M277.60M427.07M395.81M383.61M
EBITDA191.65M192.10M169.68M303.96M265.31M235.72M
Net Income56.19M50.37M40.20M147.15M137.80M126.77M
Balance Sheet
Total Assets2.39B2.30B2.36B2.43B2.07B1.75B
Cash, Cash Equivalents and Short-Term Investments107.50M99.67M129.82M173.75M159.19M349.94M
Total Debt731.26M682.83M712.17M637.70M420.25M250.24M
Total Liabilities1.19B1.13B1.15B1.27B991.42M763.97M
Stockholders Equity1.20B1.17B1.22B1.17B1.07B986.69M
Cash Flow
Free Cash Flow88.65M39.28M-85.46M-140.79M-122.35M109.42M
Operating Cash Flow127.44M162.05M174.88M160.76M72.14M235.22M
Investing Cash Flow-118.94M-116.94M-258.67M-308.09M-376.83M-139.03M
Financing Cash Flow-21.77M-64.52M33.28M166.21M117.33M-64.93M

Stepan Company Technical Analysis

Technical Analysis Sentiment
Negative
Last Price48.68
Price Trends
50DMA
54.59
Negative
100DMA
53.32
Negative
200DMA
59.61
Negative
Market Momentum
MACD
-1.75
Positive
RSI
34.38
Neutral
STOCH
47.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCL, the sentiment is Negative. The current price of 48.68 is below the 20-day moving average (MA) of 51.84, below the 50-day MA of 54.59, and below the 200-day MA of 59.61, indicating a bearish trend. The MACD of -1.75 indicates Positive momentum. The RSI at 34.38 is Neutral, neither overbought nor oversold. The STOCH value of 47.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SCL.

Stepan Company Risk Analysis

Stepan Company disclosed 20 risk factors in its most recent earnings report. Stepan Company reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Stepan Company Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$2.72B43.907.06%56.87%
65
Neutral
$1.12B19.484.77%3.14%2.64%66.43%
61
Neutral
$2.06B110.001.55%1.96%-5.45%-87.13%
58
Neutral
$2.44B41.89-0.69%3.76%1.49%-105.20%
55
Neutral
$1.99B-106.83%-14.45%49.92%
51
Neutral
$2.19B59.33-87.50%4.52%2.48%-459.90%
44
Neutral
C$930.37M-8.96-0.02%2.69%23.24%-42.45%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCL
Stepan Company
48.68
-24.86
-33.80%
IOSP
Innospec
83.30
-24.19
-22.50%
OLN
Olin
21.28
-20.56
-49.14%
CC
Chemours Company
14.95
-2.49
-14.28%
NGVT
Ingevity
55.35
19.02
52.35%
PRM
Perimeter Solutions
18.65
8.15
77.62%

Stepan Company Corporate Events

DividendsFinancial Disclosures
Stepan Company Announces Quarterly Cash Dividend
Positive
Jul 30, 2025

On July 30, 2025, Stepan Company announced a quarterly cash dividend of $0.385 per share, payable on September 15, 2025. The company reported a 19% increase in net income for the second quarter of 2025, driven by growth in its Polymers and Crop Productivity businesses, despite challenges such as start-up costs and environmental reserve adjustments. The company also highlighted a 7% increase in net sales, attributed to higher selling prices and favorable product mix, while facing a negative free cash flow due to increased working capital needs.

Executive/Board Changes
Stepan Company Appoints New CFO Ruben Velasquez
Neutral
Jul 14, 2025

On July 14, 2025, Stepan Company announced the appointment of Ruben Velasquez as Vice President and Chief Financial Officer, effective July 15, 2025. Velasquez, who brings over two decades of global finance leadership experience, previously held senior finance roles at 3M Company and Ecopetrol. His appointment is expected to bolster Stepan’s financial leadership, as he succeeds Samuel Hinrichsen, who will continue as Vice President of Finance.

Executive/Board Changes
Stepan Company Appoints Corning Painter as Director
Neutral
Jun 9, 2025

On June 9, 2025, Stepan Company announced the appointment of Corning Painter as a Director, expanding the Board to eight members. Painter, who is the CEO of Orion S.A. and has extensive experience in the chemical industry, will also join several key committees, bringing strategic and operational expertise to the company.

Private Placements and Financing
Stepan Company Issues $75 Million in Senior Notes
Neutral
May 21, 2025

On May 21, 2025, Stepan Company issued and sold $75 million in aggregate principal amount of 6.17% Senior Notes, divided equally between Series 2025-A and Series 2025-B, due May 21, 2033. The issuance is part of agreements with NYL Investors LLC and PGIM, Inc., and includes financial covenants and default provisions. The notes are guaranteed by Stepan’s subsidiaries, Stepan Specialty Products, LLC and Stepan Surfactants Holdings, LLC.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2025